Download

Download Full Text (1.1 MB)

Document Type

Poster

Description

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that results in debilitating illnesses like: emphysema, COPD, liver disease, and panniculitis. AATD is highly under-diagnosed based on epidemiologic and population studies that suggest that fewer than 10% of the 60,000-100,000 individuals in the U.S. suspected to have severely deficient alleles have been identified ( Rahaghi et al., 2012). This study examines strategies aimed at improving detection of AATD. The findings indicate that utilizing flags to alert providers of the need for AATD testing initiated by RTs or automated within EMR systems are effective strategies for increasing testing rates and potentially improving detection of emphysema and COPD secondary to AATD therefore eliminating diagnostic delays and improving prognosis for those affected.

Department

Physician Assistant Studies

Degree Name

Master of Physician Assistant Studies (MPAS)

Publication Date

2017

Keywords

alpha 1-Antitrypsin Deficiency -- complications; alpha 1-Antitrypsin Deficiency -- diagnosis; Pulmonary Emphysema -- diagnosis; Pulmonary Disease, Chronic Obstructive -- diagnosis

Disciplines

Respiratory Tract Diseases

Alpha-1 Deficiency: Better Detection May Improve Outcomes for COPD Patients

Share

COinS